Rezultati - Nilofer S. Azad

Refine Results
  1. 1
    Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)

    Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma) od Christopher Jakubowski, Nilofer S. Azad

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future

    Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future od Eric S. Christenson, Elizabeth M. Jaffee, Nilofer S. Azad

    Izdano 2020
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    The future of epigenetic therapy in solid tumours—lessons from the past

    The future of epigenetic therapy in solid tumours—lessons from the past od Nilofer S. Azad, Cynthia A. Zahnow, Charles M. Rudin, Stephen B. Baylin

    Izdano 2013
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Colorectal Cancer in the Young: Epidemiology, Prevention, Management

    Colorectal Cancer in the Young: Epidemiology, Prevention, Management od Rebecca L. Siegel, Christopher Jakubowski, Stacey A. Fedewa, Anjee Davis, Nilofer S. Azad

    Izdano 2020
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Keratoacanthomas associated with sorafenib therapy

    Keratoacanthomas associated with sorafenib therapy od Heidi H. Kong, Edward W. Cowen, Nilofer S. Azad, William L. Dahut, Martin Gutierrez, Maria L. Turner

    Izdano 2006
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

    Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease od Michael Boyiadzis, John M. Kirkwood, John L. Marshall, Colin C. Pritchard, Nilofer S. Azad, James L. Gulley

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Current Surgical Management Strategies for Colorectal Cancer Liver Metastases

    Current Surgical Management Strategies for Colorectal Cancer Liver Metastases od Gabriel D. Ivey, Fabian M. Johnston, Nilofer S. Azad, Eric S. Christenson, Kelly J. Lafaro, Christopher R. Shubert

    Izdano 2022
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Mutational profiling of colorectal cancers with microsatellite instability

    Mutational profiling of colorectal cancers with microsatellite instability od Elaine I. Lin, Li‐Hui Tseng, Christopher D. Gocke, Stacy Reil, Dung T. Le, Nilofer S. Azad, James R. Eshleman

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma

    Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma od Diane K. Reyes, Josephina A. Vossen, Ihab R. Kamel, Nilofer S. Azad, T. Wahlin, Michael Torbenson, Michael A. Choti, Jean-François H. Geschwind

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

    Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis od Arsen Osipov, Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng, Elizabeth M. Jaffee, Hao Wang, Mark Yarchoan

    Izdano 2020
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    A randomized pilot trial of a telephone‐based couples intervention for physical intimacy and sexual concerns in colorectal cancer

    A randomized pilot trial of a telephone‐based couples intervention for physical intimacy and sexual concerns in colorectal cancer od Jennifer Barsky Reese, Laura S. Porter, Katelyn R. Regan, Francis J. Keefe, Nilofer S. Azad, Luis A. Díaz, Joseph M. Herman, Jennifer A. Haythornthwaite

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models

    Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models od Chaoxin Hu, Tikva Dadon, Venugopal Chenna, Shinichi Yabuuchi, Rajat Bannerji, Robert Booher, Peter R. Strack, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    <i>GPX3</i> promoter methylation predicts platinum sensitivity in colorectal cancer

    <i>GPX3</i> promoter methylation predicts platinum sensitivity in colorectal cancer od Lorraine Pelosof, Sashidhar R. Yerram, Todd D. Armstrong, Nina J. Chu, Ludmila Danilova, Breann Yanagisawa, Manuel Hidalgo, Nilofer S. Azad, James G. Herman

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity

    Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity od Jang‐Ming Lee, Gisele Sarosy, Christina M. Annunziata, Nilofer S. Azad, Lori M. Minasian, Herb Kotz, James E. Squires, Nicole Houston, Elise C. Kohn

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status

    Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status od Jennifer Barsky Reese, Patrick H. Finan, Jennifer A. Haythornthwaite, Maura Kadan, Katelyn R. Regan, Joseph M. Herman, J. Efron, Luis A. Díaz, Nilofer S. Azad

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers

    Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers od Lisa Haley, Li‐Hui Tseng, Gang Zheng, Jonathan C. Dudley, Derek A. Anderson, Nilofer S. Azad, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases

    Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases od Georgios Karagkounis, Michael Torbenson, Hubert Darius Daniel, Nilofer S. Azad, Luis A. Díaz, Ross C. Donehower, Kenzo Hirose, Nita Ahuja, Timothy M. Pawlik, Michael A. Choti

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

    The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma od Rachna T. Shroff, Mark Yarchoan, Ashley O’Connor, Denise Gallagher, Marianna Zahurak, Gary L. Rosner, Chimela Ohaji, Susan Sartorius‐Mergenthaler, Vivek Subbiah, Ralph Zinner, Nilofer S. Azad

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours od Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

    Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017 od Milind Javle, Sunyoung Lee, Nilofer S. Azad, Mitesh J. Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora A. Janjan, Shreekant Parasuraman, Tanios Bekaii‐Saab

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: